Cargando…
Formulation and evaluation of sublingual tablets containing Sumatriptan succinate
OBJECTIVE: Sumatriptan succinate is a selective 5-hydroxytryptamine-1 receptor agonist effective in the acute treatment of migraine headaches, having low bioavailability of about 15% orally due to first-pass metabolism. The purpose of this research was to mask the intensely bitter taste of Sumatript...
Autores principales: | Prajapati, Shailesh T, Patel, Parth B, Patel, Chhagan N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555012/ https://www.ncbi.nlm.nih.gov/pubmed/23373008 http://dx.doi.org/10.4103/2230-973X.104400 |
Ejemplares similares
-
Formulation and evaluation of bucco-adhesive tablets of sumatriptan succinate
por: Prasanna, R Indira, et al.
Publicado: (2011) -
Preparation and evaluation of sublingual tablets of zolmitriptan
por: Prajapati, Shailesh T, et al.
Publicado: (2014) -
Formulation and optimisation of raft-forming chewable tablets containing H(2) antagonist
por: Prajapati, Shailesh T, et al.
Publicado: (2012) -
Formulation and Evaluation of Controlled-Release Tablet of Zolpidem Tartrate by Melt Granulation Technique
por: Prajapati, Shailesh T., et al.
Publicado: (2011) -
In vivo bioavailability studies of sumatriptan succinate buccal tablets
por: Shivanand, K, et al.
Publicado: (2011)